NCT05938452View on ClinicalTrials.gov

Safety and Tolerability of Glyceryl Tribenzoate (GTB) Capsules in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

October 19, 2023

Study Completion Date

October 19, 2023

Conditions

Neurological Disorder

Interventions

DRUG

Glyceryl Tribenzoate

Oral Solution

Trial Locations (1)

07003

TKL Research, Bloomfield

Sponsors

Collaborators (1)

Liberyx Therapeutics Ltd.

All Listed Sponsors

collaborator

Liberyx Therapeutics Ltd.

UNKNOWN

lead

Forest Hills Lab

INDUSTRY

NCT05938452 - Safety and Tolerability of Glyceryl Tribenzoate (GTB) Capsules in Healthy Subjects | Biotech Hunter | Biotech Hunter